Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review Teva Pharmaceutical Industries, 20 Jan 2015 Accessed on 27 Jan 2015 from http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-newsArticle&ID=2008891. CommentRecommendBookmarkWatch